Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care (OPTISORT)

April 15, 2026 updated by: Lille Catholic University

Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care, From Hospital to Home: Impact on Readmission at 30 Days After Delivery

This study evaluates the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days after hospital discharge. It compares a group of patients receiving comprehensive care (medication reconciliation at hospital entry, multidisciplinary medication review, and medication reconciliation at discharge), versus another group that does not benefit from the program.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

109

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients hospitalized in the department of short geriatric stay

Exclusion Criteria:

  • Patients already included in the study, and readmitted in the same service.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Standard healthcare procedures
Experimental: experimental: Reconciliation group
medical reconciliation at admission, multidisciplinary medication review, medical reconciliation at discharge of the hospital
Other: global care
Medication Reconciliation at admission, Multidisciplinary medication review, Medication Reconciliation at discharge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of readmission at 30 days
Time Frame: 30 days
Evaluate the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days of return to home.Only direct re-admissions to emergency and geriatric short-stay services in participating centres will be counted.
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time between discharge and first readmission
Time Frame: 30 days
Evaluate the impact of medication management on the time required for the first re-admission to hospital, if it takes place before 30 days.
30 days
Rate of changes in the prescription after hospital discharge by the general practitioner
Time Frame: 30 days
Estimate the impact of this process on the preservation of the prescription after hospital discharge by general practitioner within the 30 days following the return home actual number of discrepancies, what may have caused the change and which are the concerned drugs
30 days
Identification of Seniors at Risk (ISAR) score
Time Frame: 30 days
This score is based on 6 yes/no questions. T e total scale range is from 0 to 6. Each item is scored 1 if there is a problem or 0 if there is not, being the maximum score =6.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lille Catholic University

Investigators

  • Principal Investigator: Fabien Visade, MD, GHICL

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 18, 2018

Primary Completion (Actual)

December 17, 2018

Study Completion (Actual)

January 17, 2019

Study Registration Dates

First Submitted

September 10, 2018

First Submitted That Met QC Criteria

September 10, 2018

First Posted (Actual)

September 12, 2018

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 15, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC-P0069

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe